ClinicalTrials.gg
RecruitingNCT07260227IPSILONUpdated Nov 20, 2026

Influence of a PSychological Intensive Support Program for Lung Cancer Patients ON Post-operative Outcomes.

An interventional study of HADS (Hospital Anxiety and Depression Scale) in NSCLC, Anxiety Postoperative and Depression, sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.
Updated Nov 20, 2026Now RecruitingFirst site in Italy+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
138
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 103 studies in Depression with a site in Italy — 33 open to participants now, 34 under way, 2 of them phase 3. Depression · Italy.

Planned enrollment
30th of 75
138 · median 104
Started
2025
with 12 others
No phase
48 of 103
21 open now
Primary completion
2027-01
later than 21 of 33 live
Registered
97th of 103
by date
Lead sponsor
5 of 103
Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Among the 103 studies in Depression with a site in Italy, this one is the 30th largest by planned enrollment of the 75 interventional ones that give a count, is one of 13 that started in 2025, is one of 48 with no phase, reaches primary completion later than 21 of the 33 other live ones, and was the 97th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

33 of the 103 studies in Depression with a site in Italy are open now. Recruiting first, the newest first:

27 more — sign in →

All 33 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 103 studies in Depression with a site in Italy, or all of them as a file.
02

Study summary

Anxiety is common among patients diagnosed with lung cancer, affecting 50-60% of cases, and over 30% report moderate to severe psychological distress. This distress includes symptoms such as depression, anxiety and social withdrawal. The waiting period before lung resection often heightens emotional tension due to fears about reduced respiratory function and postoperative dyspnea. Persistent anxiety may continue during follow-up because of the risk of recurrence and the potential need for adjuvant therapy. Previous studies have shown that high perioperative anxiety is associated with longer hospitalization, increased complications, particularly delirium and cardiac arrhythmias, and poorer adherence to treatment.

This study aims to assess whether a brief, intensive preoperative psychological intervention reduces anxiety levels in lung cancer patients, measured using the Hospital Anxiety and Depression Scale (HADS). Scores of 0-7 indicate normal levels, ≥ 8 probable anxiety or depression. Additional tools include the Visual Analogue Scale (VAS) for pain (0 = no pain, 10 = worst pain imaginable) and the Insomnia Severity Index (ISI) (0-7 no insomnia, 8-14 subthreshold, 15-21 moderate, 22-28 severe). At hospital discharge, patients were invited to complete a questionnaire about satisfaction. Measurement of psychological test will be collected at the first visit (T0), the day before surgery (T1) and 30 day after surgery (T3); VAS and ISI measurements were collected at T1, the day after surgery (T2) and 30 day after surgery (T3).

Patients are divided into three groups: an intervention group receiving four weekly 45-minute psychological sessions, a pathological control group refusing support, and a healthy control group without anxiety. Primary outcomes are changes in HADS scores between T0 and T1; secondary outcomes include complications, pain, insomnia, length of stay, and patient satisfaction. The study is a twelve-month prospective controlled trial with an estimated 46 patients per group

03

Conditions studied

  • NSCLC
  • Anxiety Postoperative
  • Depression

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age more than 18
  • candidate to thoracic resection for lung cancer with radical intent
  • consent to participate in the research study.

Exclusion criteria

Exclusion Criteria:

  • synchronous cancer requiring chemo or radiotherapy
  • history of chronic pain, vulnerable patients (e.g., minors and/or incapacitated subjects)
  • patients with severe psychiatric conditions (psychosis and/or personality disorders).
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
138 participants (estimated)

Study arms

  • Experimental
    Study Group

    patients who resulted anxious at psychological tests who accepted the intensive psychological support

    Other: HADS (Hospital Anxiety and Depression Scale)

  • Active comparator
    "Pathological "Control Group

    patients who resulted anxious at psychological tests who refused the intensive psychological support

    Other: HADS (Hospital Anxiety and Depression Scale)

  • Active comparator
    "Healthy" Control Group

    patients who resulted not anxious at psychological tests

    Other: HADS (Hospital Anxiety and Depression Scale)

Interventions

  • OtherHADS (Hospital Anxiety and Depression Scale)

    The psychological treatment, for those patients who accepted the enrollment, consists of a weekly 45-minute psychological session for 4 weeks before the recovery in the thoracic department for lung resection. Measurement of psychological test will be collected at the first visit (T0), the day before surgery (T1) and 30 day after surgery (T3); VAS and ISI measurements were collected at T1, the day after surgery (T2) and 30 day after surgery (T3).

    Also known as: psychological evaluation

06

What researchers measure

Primary outcomes

  1. Hospital Anxiety and Depression Scale (HADS)

    The primary endpoint is the reduction in anxiety and depression as measured by the subscales of the Hospital Anxiety and Depression Scale (HADS) between T0 and T1 among the study groups. The cut-off to identify potential cases of anxiety is: 0-7: Normal; 8-10: Borderline; 11 or higher: Probable anxiety Patients with a score greater than/equal to 8 will be proposed to be enrolled into the interventional intensive psicological program.

    Time frame: 1 day

Secondary outcomes

  1. evaluation of the incidence of complications

    Secondary endpoints are to evaluate the incidence of complications (in terms of delirium, cardiac complications), perception of pain, insomnia and length of stay in the study group compared to the two control groups.

    Time frame: 1 month

07

Study locations

1 of 1 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Jan 2027, 13 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 13 months is below that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 21, 2025
First posted
Dec 3, 2025
StartActual
Dec 1, 2025
Primary completionEst.
Jan 31, 2027
CompletionEst.
Apr 30, 2027
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 20, 2026
Sites
1 site added — first site in Italy
Show site
  • Fondazione Policlinico Uniiversitario A Gemelli IRCCS · Roma, Italy
Nov 20, 2026
Interventions
Arm changed Pathological Control Group→"Pathological "Control Group; Healthy Control Group→"Healthy" Control Group
Nov 20, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedHospital Anxiety and Depression Scale (HADS)Time frame: 1 day
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Italy
    Show site
    • Fondazione Policlinico Uniiversitario A Gemelli IRCCS · Roma, Italy
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedHospital Anxiety and Depression Scale (HADS)Time frame: 1 day
    Interventions Arm changed Pathological Control Group→"Pathological "Control Group; Healthy Control Group→"Healthy" Control Group
    + 2 other changes: date precision and design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07260227
Responsible party
Sponsor
First posted
Dec 3, 2025
Start date
Dec 1, 2025
Primary completion
Jan 31, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Nov 20, 2026

Study contacts

Maria Teresa Congedo
Contact
mariateresa.congedo@policlinicogemelli.it
+ 390630156845
Maria Teresa Congedo
principal investigator · Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion